-
TPS 105 ALISertib in Combination With Endocrine Therapy in Patients With Hormone Receptor-Positive, HER2-Negative Recurrent or Metastatic Breast Cancer: the Phase 2 ALISCA-Breast1 Study
12 Apr 2025 02:29 GMT
… 47;HER2–) recurrent or metastatic breast cancer, optimal treatment after … HR+ breast cancer-derived cell lines and breast cancer xenograft models … HER2–, recurrent or metastatic breast adenocarcinoma not amenable … in recurrent or metastatic setting; bone-only …
-
The Evolving Pharmacist Role in HER2-Negative Adjuvant Breast Cancer Therapy
12 Apr 2025 04:58 GMT
… receptor 2-negative (HER2-) breast cancer (BC). She discussed the challenges … for early-stage HER2-negative breast cancer?
Ziegengeist: So luckily, for … that we use in the metastatic setting. Now they’re … now, only use in the metastatic setting. And so, nothing …
-
UVA researcher wins major grant to revolutionize breast cancer treatment
12 Apr 2025 02:30 GMT
… an approach to metastatic breast cancer treatment that transforms … years from diagnosis, metastatic breast cancer remains incurable. Chemotherapy, … key bottlenecks in breast cancer treatment."
Natasha … not only primary breast tumors, but also metastases …
-
NICE recommends new combination breast cancer drug
11 Apr 2025 22:00 GMT
… new combination treatment for advanced breast cancer patients. AstraZeneca’s Truqap ( … (HR)-positive HER2-negative breast cancer with certain genetic mutations.
In … HER2-negative, locally advanced or metastatic breast cancer. The decision was based on …
-
Pill that can slow breast cancer cleared for NHS use
11 Apr 2025 19:52 GMT
… HR-positive, HER2-negative metastatic breast cancer that also has one … with advanced HR-positive breast cancer, but at the moment … people with incurable secondary breast cancer the hope of more … Rowney, chief executive at Breast Cancer Now.
However, " …
-
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
11 Apr 2025 13:41 GMT
… AstraZeneca’s already-marketed breast cancer drug Faslodex (fulvestrant). … locally advanced or metastatic are eligible for … Novartis’ Kisqali (ribociclib).
Breast cancer is the most common … negative breast cancer is the most common type of breast cancer. …
-
Tahira Kashyap’s Breast Cancer Relapses After 7 Years: Little-Known Facts About Recurrence
11 Apr 2025 12:01 GMT
… about recurrent breast cancer.
Recurrent breast cancer happens when … Of Recurrent Breast Cancer
Recurrent Breast Cancer occurs when … referred to as metastatic breast cancer.
Notably, if … Inflammatory Breast Cancer (IBC) and Triple-Negative Breast Cancer (TNBC …
-
Dr Escobar on CDK4/6 Inhibitor Selection in HR+ Metastatic Breast Cancer
09 Apr 2025 21:45 GMT
… [for patients with HR-positive metastatic breast cancer].”
Mauricio Escobar, MD, an … with hormone receptor (HR)–positive metastatic breast cancer.
Currently, prospective research has … the others in HR-positive metastatic breast cancer, Escobar began. He noted …
-
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
10 Apr 2025 20:18 GMT
… five cases involving lymph node metastasis.
For every one second … Breast Cancer?,” “Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers … Response to Neoadjuvant Chemotherapy for Breast Cancer?”)
Beyond the inherent limitations …
-
Researchers discover 'smart bomb' targeted therapy to destroy breast cancer
10 Apr 2025 18:02 GMT
… chemicals to treat breast cancer, proving effective in … way to treat breast cancer.
They developed light … (PDT). They destroy metastatic breast cancer tumors.
Currently, the research … treatment completely eradicated metastatic breast cancer tumors in mice …